B · Normal
[Linuo Medicine Kit: The controlling shareholder and specific shareholders plan to reduce their holdings by no more than 4% of the shares] On September 7, Linuo Medicine Kit (301188.SZ) announced that the controlling shareholder Linuo Investment plans to reduce its holdings by no more than 4% through block transactions. More than 5.1891 million shares, accounting for 2% of the total share capital; specific shareholders Fosun Weishi and its concerted actors Fosun Weiying plan to reduce their holdings by a total of no more than 5.1891 million shares, accounting for 2% of the total share capital, through centralized bidding and block transactions. The holding reduction period is from September 30 to December 29, 2026.
Comments